Inspire Medical Systems Inc (INSP)

Industry Medical Devices

This stock can be held in an Investment ISA and an Investment Account

Sell

$54.60

Buy

$55.00

arrow-up$1.35 (+2.52%)

Prices updated at 02 Apr 2026, 23:00 EDT

Prices minimum 15 mins delay

Prices in USD

Inspire Medical Systems Inc operates as a medical technology company. The firm develops implantable neurostimulation systems to treat obstructive sleep apnea.

S&P 500

0.11%

NYSE

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

Sector

Healthcare

Industry

Medical Devices

Chairman

Mr. Timothy P. Herbert

CEO

Mr. Timothy P. Herbert

Most recent earnings

31 Dec 2025

Fiscal year end

31 Dec 2025

Employees

1,333

Head office

5500 Wayzata Boulevard

Golden Valley

United States

55416

+1 844 672-4357

Bob@LifeSciAdvisors.com

Company website

Key personnel

Owner name chevron-l-regular chevron-r-regular	Salary
Mr. Richard J. Buchholz Interim Chief Financial Officer and Principal Accounting Officer	0.48m
Mr. Bryan K. Phillips Senior Vice President, General Counsel, Chief Compliance Officer and Corporate Secretary	0.48m
Mr. Gary L. Ellis Lead Independent Director	0.11m
Mr. Dana G. Mead, Jr Independent Director	0.08m
Mr. Shawn T. McCormick Independent Director	0.08m
Ms. Shelley G. Broader, B.A. Independent Director	0.08m
Mr. Casey M. Tansey Independent Director	0.07m
Dr. Myriam J. Curet, F.A.C.S.,M.D. Independent Director	0.07m
Mr. Timothy P. Herbert Chief Executive Officer, President and Chairman of the Board	0.75m
Ms. Georgia Garinois-Melenikiotou Independent Director	0.07m
Mr. Matthew J. Osberg Chief Financial Officer	-
Mr. John C. Rondoni Chief Product and Innovation Officer	-
Ms. Cynthia B. Burks Independent Director	0.07m
Mr. Carlton W. Weatherby Chief Strategy Officer and Chief Growth Officer	0.51m
Ms. Melissa Mann Chief People Officer	-
Mr. Jason P. Kelly Chief Operations and Quality Officer	-

Top 5 shareholders

Owner name chevron-l-regular chevron-r-regular	No. of shares
BlackRock Inc	3,547,195
Vanguard Group Inc	2,953,170
BlackRock Fund Advisors	2,466,909
Wellington Management Company LLP	2,211,091
iShares Core S&P Small-Cap ETF	1,561,061

Director dealings

Date chevron-l-regular chevron-r-regular	Action
02 Dec 2025	-
28 Nov 2025	-
14 Oct 2025	-
14 Oct 2025	-
14 Oct 2025	-
14 Oct 2025	-
29 Aug 2025	-
19 Aug 2025	-
19 Aug 2025	-
19 Aug 2025	-
19 Aug 2025	-
19 Aug 2025	-
19 Aug 2025	-
19 Aug 2025	-
15 Jul 2025	-
15 Jul 2025	-
15 Jul 2025	-
15 Jul 2025	-
04 Jun 2025	-
04 Jun 2025	-

Please note that past performance is not a reliable indicator of future returns.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.